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In our days more and more people live with chronic conditions, which will account for nearly 
three quarters of global mortality in 2020 [1]. The quest for sustainable financing of 
healthcare systems needs to embrace efficient approaches in the management of chronic 
conditions [2]. Over the last decades, patient-centredness has gained considerable attention 
in medicine, which, by putting patients’ values and preferences in the forefront of medical 
decision-making, aims for their more efficient involvement as partners in the health 
production process [3, 4]. The active involvement of patients is particularly important in the 
reduction of modifiable lifestyle-related risks, which contribute to a considerable share of 
excess mortality from chronic conditions [5]. Since large-scale policy measures such as 
changes of income or education, that can influence important individual determinants of 
health and healthy behaviours potentially span in time over generations, personally 
acquired potentials, which can develop over later courses of life, such as knowledge, skills, 
positive emotions and engagement are of particular importance from both public health 
and health economic perspective [6, 7]. A number of theories, such as internal locus of 
control [8], self-efficacy [9] or self-management [10] or the transtheoretical model of 
change [11] have addressed the drivers of change in health behaviours, and a number care 
delivery models, such as the Chronic Care Model promoted systematic improvements 
involving patient-centredness, support for self-management, evidence-based proactive 
interventions, integrated team-care and supportive information technology solutions [12]. 
Digital health interventions have been shown to be effective in promoting healthy 
behaviours through patient education or supporting behaviour change, and upon the 
demonstration of adequate supportive evidence, authorities are now considering their 
adoption among publicly financed health technologies [13, 14].  
The Patient-Activation Measure (PAM) has been developed to serve as a reliable patient-
reported outcome measure (PROM) that can measure the skills, knowledge and motivation 
of patients that are necessary for their effective contribution to their own care, and 
eventually predict better outcomes [15]. Since its development, PAM has become an 
officially adopted PROM by the National Institute of Health of the US and the National 
Health Service of the UK, its validated versions have been available in over 20 countries and 
it has been applied in over 500 studies worldwide [16]. It has been demonstrated that 
higher PAM values are associated with better health outcomes [17], fewer lifestyle-related 
risks [18], better adherence to therapy [19], and lower use of healthcare resources [18, 
20].Furthermore, it has been shown that patient activation can be improved via digital 
health interventions [21, 22] as well as offline patient-support programs [23].  
In accordance with national policies aiming to reduce lifestyle related excess mortality as 
well as the advancement of digital health [24], our aim was to adapt and validate the 
abbreviated PAM-13 tool in Hungary to serve as a widely tested and internationally 
recognised instrument in the development or monitoring of evidence-based health-




In April 2020 we conducted an online survey recruiting 900 respondents from a large online 
panel via quota-based sampling with strata set according to the 2011 population census. 
[25]. Our sample was representative of the 40+ years old Hungarian population in terms of 
age groups (40-49, 50-59, 60-69 and 70+ years old), gender, education (primary, secondary 
and tertiary), geographic region (7 NUTS-2 regions) and type of residence (village, town or 
capital city). After 10 days, 100 respondents were randomly selected for repeat 
administration of the entire survey. We considered 10 days lag sufficient to prevent recall, 
yet capture a stable PAM-13 status [26-28]. Ethical approval was granted by the National 
Medical Research Council (TUKEB, ID: 49702-3/2019/EKU) and applicable licenses were 
obtained for the instruments (PAM-13, EQ-5D). Data collection was performed by an online 
research firm, NRC Kft.  
 
Translation of PAM 
The Hungarian language version of the PAM-13 questionnaire was produced in accordance 
with the WHO guidelines for the translation and adaptation of instruments [29]. Forward- 
translation was performed by two independent experts, the back-translation was carried 
out by two bilingual translators and elaborated by two researchers (DÁ and ZZ) against the 
original version of the instrument. The draft instrument was piloted along with cognitive 
debriefing on 10 respondents including both males and females from different age groups. 
The literal translations were overridden at several questions with natural phrases that were 
considered to be acceptable for the broadest audience, yet conceptually equivalent with the 
original questionnaire. The pre-final version was consulted with the developers of the PAM 
instrument. The 4-level Likert scale response options of the original instrument (“Disagree 
strongly”, “Disagree”, “Agree”, “Agree strongly”) were slightly modified to mark more 
precisely the scale degrees in a Hungarian context (“Completely disagree”, “Rather 
disagree”, “Rather agree”, “Completely agree”). The Hungarian PAM-13 is attached in 
[Electronic Supplementary Material Sx.]  
The survey questionnaire  
PAM-13 
PAM-13 assesses one’s knowledge, skill and confidence for self-management. The 
instrument consists 13 items, scored on a 4-point Likert scale and a 5th not applicable 
option. For a valid PAM score, up to 3 not applicable responses are allowed. The items are 
ordered in increasing difficulty. Using a proprietary scoring algorithm based on Rasch 
analysis, PAM is scored on a scale of 0-100, where lower values suggest that less likelihood 
that patients engage in effective self-management. Based on their PAM scores, patients are 
grouped into four PAM levels. At level 1, patients may not understand the need to take 
active role in their health. At level 2, their confidence or skill is probably too low to take 
action, at level 3 patients are beginning to take action, and at level 4, they may endure in 
self-management even in difficult times [15, 30, 31].  
eHEALS 
eHEALS measures self-reported eHEALTH literacy using eight 5-point Likert scale items. The 
eHEALS score (range 8-40) is calculated by summing individual item scores, with higher 
values indicating greater skill levels. The Hungarian eHEALS instrument has been validated in 
the general population via an online survey [32, 33]. Since eHEALS showed weak correlation 
with objective performance tests [34, 35], we also measured performed health literacy in 
our survey.  
NVS 
The Newest Vital Sign is a frequently used screening instrument for performed health 
literacy. Respondents need to answer six questions by interpreting the information from an 
ice-cream nutritional label and performing simple arithmetic tasks. For some questions 
correct answers can be formulated in several ways. The number of correctly answered items 
are counted. A score of 0-1 indicates limited - , 2-3 indicated probably limited- , and 4-6 
indicates adequate health literacy [36]. We adapted the Hungarian NVS for online 
administration [37]. Instead of offering multiple-choice options in the online adaptation 
[38], we specified the measurement unit for answers in the questions, and evaluated the 
accuracy of free-text answers.  
EQ-5D-5L  
We measured health-related quality of life via the Hungarian version of EQ-5D-5L [39]. The 
EQ-5D-5L consists a descriptive system, which asks respondents to evaluate their current 
health in 5 dimensions (mobility, self-care, usual activities, pain/discomfort, 
anxiety/depression) using 5 levels (1: no problems, 2: mild problems, 3: moderate problems, 
4: severe problems, 5: extreme problems). By combining the problem levels in each 
dimension, the EQ-5D-5L can describe 3125 (55) discrete health profiles, to which utility 
values are attached reflecting preferences of the general population. We used the 
Hungarian value-set in our study [40]. As part of EQ 5D, we also applied the EQ VAS, which is 
a 20-cm vertical visual analogue scale asking respondents to evaluate their current health 
between the two extremes of 0 (worst imaginable health) and 100 (best imaginable health).  
MEHM 
We also inquired respondents’ health by the Minimal European Health Module (MEHM). 
The MEHM consists of three questions. Self-perceived health evaluates current health on a 
5-point Likert scale (Very good; Good; Fair; Bad; Very Bad). The Global Activity Limitation 
Indicator (GALI) asks limitations in activities over the past 6 months due to a health problem 
(Not limited, Limited but not severely, Severely limited). A final item (Chronic Morbidity) 
inquires the presence of long-standing health problems [41].  
Health-related information seeking and online behaviours 
We constructed seven items to assess the frequency of various health-related information 
seeking and online behaviours over the past 12 months. Item 1 inquired about health 
information seeking in general and item 2 about participation at patient-education 
programs. Items 3-7 inquired about health-related use of the internet or mobil devices in 
different functional domains, motivated by the classification of the evidence standards 
framework of digital health interventions proposed by NICE [14]. Item 3 inquired general 
health-related administration, item 4 about health-related information seeking, item 5 
about health-related communication with HCPs, helpers or peer patients, item 6 about 
health prevention activities and item 7 about disease management activities using the 
internet or mobil devices. All items were scored on a 6-point Likert scale (never, few times 
past year, bimonthly, monthly, several times per month, at least once a week). 
Demographic variables 
We recorded basic demographic variables and defined the following subgroups: age (40-
49,50-59, 60-69, 70+ year olds), gender (male, female), family status (single, married, 
domestic partnership, divorced, widowed and other), education (primary, secondary, 
tertiary), health professional qualification (yes, no), type of settlement (capital, town, 
village), NUTS2 region and the place of residence based on poscode. Net monthly household 
income was queried in 11 range categories, and per-capita household income was 
calculated by dividing the category mid-range values by the number of household members, 
without adjustment for the number of children. The mid-range value of the upper open 
category was calculated by fitting the Pareto curve as proposed by Parker and Fenwick [42]. 
Local currency values were transformed to Euros using the average exchange rate for the 
period of Apr 1, 2019 Apr 1,-2020 (330.7 HUF/EUR) [43]. We also recorded respondents’ 
level of happiness using the 10-point numeric happiness scale [44]. Although not in scope 
for our current research goals, we also recorded healthcare resource use, out-of-pocket 
expenditure and general wellbeing using the capability-based ICECAP-A and ICECAP-O 
instruments [45-48].  
Lifestyle risks 
We recorded the most common modifiable risk factors for all-cause mortality and chronic 
conditions, such as BMI, smoking, alcohol intake, dietary habits, physical activity and 
sedentary behaviour [49-53]. Lifestyle-risk (LR) were inquired via single-question self-
reported items. In order to represent similar “severity levels”, the following LR cutoff values 
were chosen that represent approximately 1.4-fold or greater relative risk increase for 
overall mortality: BMI <18.5 or BMI ³30 [54], current smoking [55, 56], sedentary behaviour 
³8 hours per day with <150 min exercise per week or no exercise at all [57], no fruit or 
vegetable intake [58] and binge drinking ³1 day per week [59]. Binge drinking was defined 
as >5 drinks / occasion for men and >4 drinks / occasion for women [59, 60]. We also 
generated LR index (LRI) by adding the number of LR’s for each patient. Based on their LR 
index, respondents were assigned to risk groups using stringent- (no LR vs any LR) and 
relaxed (0-1 LR vs 2-4 LR) criteria.  
Preventive behaviours 
We considered the participation at screenings and vaccination programs as preventive 
behaviours, which are prescribed by Hungarian law [61, 62]. According to this, for females 
we counted the participation at cervical cancer screening between 25-65 years of age, 
breast cancer screening between 45-65 years of age, colorectal screening between 50-70 
years of age, blood pressure, blood glucose and cholesterol levels measured within a year, 
flu vaccination at 60+ years of age and bacterial pneumonia vaccination at 50+ years of age. 
For males we counted the participation at prostate cancer colorectal cancer screening 
between 50-70 years of age, blood pressure, blood glucose and cholesterol levels measured 
within a year, flu vaccination at 60+ years of age and bacterial pneumonia vaccination at 50+ 
years of age. In order to make respondents with different gender and age comparable, we 
calculated the preventive behaviour score (PBS) as the proportion of performed preventive 
behaviours compared to the maximum of preventive behaviours prescribed for a given age 
and gender. For example, having only blood pressure measured within a year would 
represent a PBS of 0.33 for a 40-year-old man (with only blood pressure, glucose and 
cholesterol check recommended), while it would be a PBS of 0.125 for a 60-year-old 
woman, (for whom cervix-, breast- and colorectal cancer screenings, blood pressure, 
glucose and cholesterol tests, as well as flu and bacterial pneumonia vaccinations are 
recommended). We also grouped respondents based on their PBS (<50%, ³ 50%).  
Excluded respondents 
Before data analysis, we checked the dataset for outliers and based on group consensus, we 
set implausible values to missing, or deleted entire records in case of potentially unreliable 
answer patterns. We deleted the data point if sedentary time was reported >18 hours / day, 
and we deleted cases if the frequency of online health information seeking was reported 
over two categories greater than general health information seeking, response times for 
shorter than 4 second per item for the survey instruments (PAM-13, eHEALS, ICECAP-A, 
ICECAP-O), or shorter than 1 minute for the NVS instrument. One respondent was excluded 
due to unlikely body parameters (height 111 cm, weight 200 kg, BMI=162), and based on 
the PAM license owner’s recommendation, we dropped individuals with a PAM-13 score of 
0 and 100 as well as ones with not applicable answers in more than 3 PAM-13 items [63].  
Statistical methods 
We followed the applicable COSMIN guidelines for patient-reported outcome measurement 
instruments when planning the methods of our study [64-66]. Missing data, descriptive 
statistics and distributional properties were asessed for all variables. The distribution of PAM-
13 scores was assessed via inspection of the histogram and quantile-plot, and normality was 
tested via the Shapiro–Wilk test. Floor- and ceiling effects (frequency of the highest and 
lowest scores in the sample) were assessed against the threshold of 15% [67]. We tabulated 
respondents based on their PAM levels.  
Reliability 
We evaluated internal consistency via computing Cronbach’s alpha. Test-retest reliability for 
PAM-13 scores was assessed by intra-class correlation coefficient of agreement using a two-
way random effects model (ICCagreement or ICC(A,1)) [68]. For categorical PAM levels, we 
calculated weighted kappa using quadratic weights to progressively penalise greater 
differences between categories [68]. Measurement error (standard error of measurement, 
SEM) was calculated using the formula !"# = % ∗ '1 − *++!"#$$%$&', where	% is the pooled 
standard deviation of the pooled sample from repeat administration. The smallest detectable 
change (SDC, the smallest change that can be detected within a single person with p<0.05 
taking measurement error into consideration) was calculated via the following formula 
!-+ = 1.96 ∗ √2 ∗ !"# [28]. We considered the following thresholds for good 
measurement properties: ≥0.7 for ICCagreement and weighted kappa, and the range of 0.7-0.95 
for Cronbach’s alpha [28].  
Validity 
Content validity was assessed during the translation process, no further quantitative 
measurements were performed. Construct validity was assessed via confirmatory factor 
analysis using robust structural equitation modelling via the R package lavaan [69], asuming 
a single underlying factor. We checked the Kaiser-Meyer-Olkin (KMO) statistic for the 
adequacy of sampling [70] and Bartlett-test for sphericity to check the adequacy of our data 
for factor analysis. Model fit was assessed by the RMSEA, the Tucker-Lewis index (TLI) and 
the comparative fit index (CFI), using cutoff values of  ≤0.05, 0.9 and 0.9 for good fit, 
respectively. Convergent validity was assessed by the correlation between PAM-13 scores as 
well as PAM levels and eHEALS scores, based on the assumption that both instruments 
measure advanced knowledge and are conceptually related to self-efficacy [15, 33]. We 
expected significant positive relationship between the two measures. Discriminant validity 
was tested by the expectation of weak or non-significant correlation between PAM-13 
scores and levels and age, education and income, based on the assumption that PAM 
measures qualities that cannot be explained by socio-economic status. We applied Pearson 
correlation between continuous measures, and polyserial correlation when categorical 
measures were involved.  
When testing known-groups validity, our hypothesis was the following: patients with more 
preventive behaviours (PBS ≥50%), fewer lifestyle risks (LRI=0 or LRI ≤1), those, who were 
more active in health information seeking, patient education, online/mobile health-
information seeking- , health-related communication, disease-prevention- or disease 
management activities had higher mean PAM scores. We defined higher activity as having at 
least median scores on each item, or any activity over the past year, if majority of 
respondents did not engage in the respective online activity. The hypotheses were tested 
using one-sided Welch’s t-test. We also explored the same hypotheses in subgroups of 
patients with or without chronic disease, male or female respondents, and respondents ≥65 
years of age or younger, respondents in the lowest income group or higher and respondents 
with adequate (NVS≥4) or lower health literacy scores. We deleted missing values pairwise 





From the 900 survey respondents 779 (86.6%) individuals were eligible for the analysis 
(validation sample). For PAM-13-related quality issues we excluded 99 respondents (11.0%), 
and other 22 respondents (2.4%) due to other reasons detailed above. From retest sample 
(n=100), 11 (11.0%) had PAM-13-related quality issues, 4 (4.0%) other reasons for exclusion 
and 10 respondents were excluded in the first administration. Altogether, 75 respondents 
had matching test-retest scores (retest sample).  
In the validation sample, mean age was 60.4 (SD=10.6) years, 54.0% were female, 66.5% 
reported to have chronic disease. The demographic properties, reasons for exclusion and 
corresponding values from the general population are summarized in Table 1. [vs General 
population] 
 













  n % n % % % n % % 
Total  779 - 900 - 75 - 100 - - 
Age group 40-49 143 18 173 19 14 15 16 16 26 
50-59 177 23 200 22 14 21 22 22 28 
60-69 306 39 348 39 11 37 38 38 23 
70+ 153 20 149 20 9 27 24 24 23 
Gender Male 358 46 425 47 44 49 50 50 44 
Female 421 54 475 53 56 51 50 50 56 
Education Primary 203 26 251 28 62 45 47 47 35 
Secondary 288 37 326 36 28 33 32 32 49 
Tertiary 288 37 323 36 10 21 21 21 16 
Region Central Hungary 276 35 316 35 29 29 30 30 29 
Transdanubia 262 34 307 34 31 36 36 36 31 
Great Plain and North 241 31 277 31 40 35 34 34 40 
Type of 
residence 
Capital 181 23 209 23 17 24 22 22 17 
Town 447 57 513 57 52 48 49 49 52 
Village 151 19 178 20 31 28 29 29 31 
Income 1st quintile 75 11 103 13 20 12 17 19  
2nd quintile 106 16 119 16 20 20 17 19  
3rd quintile 74 11 85 11 20 13 13 14  
4th quintile 122 18 137 18 20 17 13 14  
5th quintile 291 44 320 42 20 38 30 33  
Missing 111 14 136 15 6 8 10 10  
Self-rated 
health 
Very good 39 5 51 6 2 3 6 6  
Good 267 34 305 34 25 33 32 32  
Fair 397 51 449 50 39 52 47 47  
Bad 66 8 79 9 8 11 13 13  
Very Bad 10 1 13 1 1 1 1 1  
Missing 0 0 3 0 0 0 1 1  
Chronic 
morbidity 
No 253 33 309 36 20 27 29 30  
Yes 503 67 560 64 54 73 68 70  
Missing 23 3 31 3 1 1 3 3  
GALI Not limited  496 64 579 65 40 53 53 54  
Limited but not severely 243 31 274 31 32 43 43 43  
Severely limited 37 5 43 5 3 4 3 3  
Missing 3 0 4 0 0 0 1 1  
Exclusion PAM-13 NA items >3  - - 51 6 - - 2 2  
All PAM-13 items „disagree 
strongly”  
- - 18 2 - - 4 4  
All PAM-13 items „agree 
strongly”  
- - 23 3 - - 5 5  
PAM-13 completion time < 52s - - 7 1 - - 0 0  
Other reasons - - 22 2 - - 4 4  
Excluded in first administration - - - - - - 10 10  
 
Mean (±SD) PAM-13, eHEALS and NVS scores were 59.8 (±11.5), 28.7 (±5.1) and 3.9 (±1.7), 
respectively. The number (%) of patients with PAM levels 1,2,3 and 4 were 124 (15.9%), 143 
(18.4%), 428 (54.9%) and 84 (10.8%), respectively. The health literacy was adequate for 491 
(63.0%), possibly limited for 197 (25.3%), and probably limited for 91 (11.7%). Mean ( ±SD) 
LRI was 1.2 (±1.0), 0, 1,2 and ≥1 LRs were reported by 210 (27.0%), 275 (35.3%), 207 (26.6%) 
and 87 (11.2%) respondents. Mean (±SD) PBS was 0.45 (±0.25). According to the cutoff 
values for hypothesis testing, 466 (59.8%) respondents searched health-related information 
at least monthly, 171 (22.0%) participated in patient education over the past year, 443 
(56.9%) performed health-related administration over the internet, 421 (54.0%) seeked 
health-related information at least bimonthly, 196 (25.2%) communicated online over past 
year about health with HCPs, helpers or peers, 280 (35.9%) engaged in online health 
prevention activities 347 (44.5%) participated in online disease-management activities over 
the past year. Further details of the key variables are summarized in the [Electronic 
Supplementary Material Sx.] 
 
Classic test theory methods 
We summarized the psychometric properties of PAM-13 along with the applied methods, 
target values, and results in Table 2. The distribution plots of PAM-13 are displayed in the 
[Electronic Supplementary Material Sx.] The results of known-groups hypothesis tests in 
multiple subgroups are summarized in the [Electronic Supplementary Material Sx].  
 
Table 2. Summary of the results of classic test theory methods 
 
Category Property Method Target Result Comment 
General Distribution Skewness 0.00 0.22; p=0.01 Positive skew 
  Kurtosis 3.00  2.85; p=0.43 Normal kurtosis 
  Shapiro–Wilk test for normal 
distribution 
p ≥0.05 p=0.049 Deviation from 
normality  
  Shapiro–Wilk test for log-
normal distribution 
p≥0.05 p=0.85 Log-normal 
distribution 
  Floor effect <15% 0.13% [0.0-0.7%]a No floor effect 
  Ceiling effect <15% 1.3% [0.6-2.3%] No ceiling effect 
Reliability Internal 
consistency 
Cronbach alpha 0.7-0.95 0.766 Adequate 
 Test-retest 
reliability 
ICCagreement >0.7 0.63 [0.47-0.75] Moderate 
  weighted kappa* >0.7 0.48 [0.29-0.68] Moderate 
  Standard error of 
measurement (SEM) 
- 7.21 - 
  Smallest detectable change 
(SDC) 
- 20.0 - 
  Absolute agreement* - 49.3% - 
Validity Structural 
validity 
Confirmatory factor analysis 
(CFA): adequate sample 
- KMO  













  Confirmatory factor analysis 
(CFA): single factor 
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Results refer to PAM-13 scores, with the exception of measures indicated with *, which refer to PAM levels. a 
95% CI values are displayed in square brackets 
 
Item-response theory methods 
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Appendix 1.  
 
13 kérdésből álló Beteg Aktivitás Kérdőívâ (PAM-13) 
 
Az alábbiakban néhány olyan állítás szerepel, melyeket az emberek az egészségükkel kapcsolatosan szoktak mondani. Kérjük, jelölje be, hogy 
mennyire ért egyet - vagy nem ért egyet - azzal, hogy Önre jellemzőek ezek az állítások. Válaszai tükrözzék azt, amit önmagára nézve igaznak 
tart, és ne azt, amiről azt gondolja, hogy mások elvárnának Öntől. 
 
Amelyik állítás nem alkalmazható Önre, annál jelölje meg a “nem jellemző” lehetőséget.  















2 Az egészségemet leginkább az befolyásolja, hogy 















Biztos vagyok benne, hogy tudok segíteni az 
egészségemmel kapcsolatos problémák 






























Biztos vagyok benne, hogy meg tudom állapítani, 
hogy egy egészségi problémával orvoshoz kell 














6 Biztos vagyok benne, hogy el tudom mondani az 














7 Biztos vagyok benne, hogy ha szükségem van rá, el 































Tudom, hogy egészségi problémáimra milyen kezelési 















Kitartó tudtam maradni, amikor életmódot 































Biztos vagyok benne, hogy találok megoldást, ha új 















Biztos vagyok benne, hogy ha életmódot változtatok 
(pl. helyes táplálkozás vagy testmozgás), akkor még 













Insignia Health, LLC®. Patient Activation Measure © 2003-2020 University of Oregon. 
Minden jog fenntartva. 
Bizalmas. Csak érvényes PAM® Licencmegállapodás mellett használható. 
Az engedélyezésért lépjen kapcsolatba az Insignia Health-szel az info@insigniahealth.com e-mail címen  
Distribution of PAM-13 scores. A) Quantile-plot vs normal distribution, B) histogram with 





























   Subgroups         























Preventive behaviours PBS≥50% 60.35 58.94 61.44 63.35 59.45 60.87 60.31 60.36 60.14 59.69 61.57 
PBS <50% 59.32 58.32 60.25 61.44 58.48 58.84 59.68 59.33 59.27 58.87 60.04 
p value 0.107 0.301 0.148 0.092 0.178 0.026 0.328 0.113 0.39 0.211 0.135 
Lifestyle risks LRI=0 63.07 62.59 63.39 63.91 63.18 64.11 61.45 62.88 65.19 62.46 64.16 
LRI≥1 58.62 57.4 59.76 61.29 57.77 58.17 59.38 58.71 57.81 58.09 59.52 
p value <0.001 <0.001 0.002 0.04 <0.001 <0.001 0.099 <0.001 0.013 <0.001 0.002 
LRI≤1 61.76 60.1 62.98 63.3 61.31 62.43 60.76 61.67 62.67 61.1 62.92 
LRI≥2 56.62 56.61 56.64 59.52 55.76 55.67 58.41 56.84 54.68 56.19 57.33 
p value <0.001 0.002 <0.001 0.005 <0.001 <0.001 0.048 <0.001 0.007 <0.001 <0.001 
Health information 
seeking 
At least montly 60.93 60.42 61.27 63.21 60.37 61.22 60.48 60.89 61.28 60.01 62.46 
Less often than monthly 58.17 56.69 60.03 60.95 56.78 57.65 59.1 58.38 55.23 58.22 58.1 
p value 0.001 0.001 0.157 0.053 <0.001 <0.001 0.162 0.002 0.042 0.041 0.001 
Patient education Over past year 61.49 59.37 62.73 65.02 60.72 61.98 60.63 61.33 62.8 60.95 62.31 
None 59.35 58.44 60.21 61.71 58.4 59.09 59.78 59.44 58.49 58.84 60.26 
p value 0.019 0.286 0.029 0.053 0.028 0.012 0.31 0.038 0.131 0.049 0.118 
Online healht 
information seeking 
At least bimonthly 60.28 59.50 61.00 63.83 59.23 60.55 60.12 60.28 60.31 59.46 61.8 
Less often than bimonthly 59.29 57.86 60.77 60.89 58.68 58.73 59.8 59.35 58.61 59.05 59.65 
p value 0.116 0.082 0.422 0.016 0.30 0.04 0.408 0.141 0.293 0.345 0.062 
Online health-related 
communication 
Over past year 61.15 60.49 61.56 63.58 60.72 61.18 61.11 61.15 61.17 60.83 61.56 
None 59.38 58.11 60.57 61.89 58.29 59.3 59.5 59.41 59.08 58.84 60.4 
p value 0.031 0.048 0.218 0.173 0.016 0.059 0.149 0.039 0.269 0.049 0.225 
Online health 
prevention activity 
Over past year 60.97 59.93 61.6 62.51 60.7 61.59 59.99 60.77 62.94 60.34 61.76 
None 59.18 58.05 60.33 61.99 58.08 58.73 59.93 59.33 57.8 58.79 59.98 
p value 0.018 0.066 0.137 0.356 0.007 0.004 0.484 0.051 0.06 0.077 0.102 
Online disease 
management activity 
Over past year 60.74 59.06 61.74 63.71 60.12 61.65 60.38 60.52 62.56 60.00 61.86 
None 59.09 58.35 59.92 61.35 57.94 58.43 59.54 59.32 56.69 58.75 59.72 
p value 0.024 0.275 0.056 0.05 0.017 0.001 0.27 0.082 0.025 0.116 0.063 
 N 779 358 421 253 503 483 296 704 75 491 288 
 
